Clinical Trials Logo

Clinical Trial Summary

This is a randomised, open-labelled, controlled trial to compare the efficacy and effectiveness on relapse-free rate of 12-week versus 20-week oral eradication treatment of melioidosis. The study population includes 800 patients with culture-confirmed melioidosis whom 12 weeks of oral eradication therapy have been completed with or without intravenous intensive antibiotics. Patients will be randomised to either stop the eradication treatment or continue current oral treatment for 8 more weeks. The study aim to optimise the regimen used to treat melioidosis for better compliance and reducing unnecessary use of antibiotics.


Clinical Trial Description

Planed interim analysis will be conducted when the patient enrollment reaches 600 cases for evaluating safety and futility of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01420341
Study type Interventional
Source Khon Kaen University
Contact
Status Completed
Phase Phase 4
Start date August 2011
Completion date June 21, 2019

See also
  Status Clinical Trial Phase
Completed NCT04299412 - Diagnostic Accuracy of the DPP II Assay
Recruiting NCT06089668 - An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
Completed NCT03528265 - Adapting LFI for Melioidosis
Completed NCT05105035 - Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients Phase 2
Completed NCT01766830 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) N/A
Recruiting NCT03048513 - Clinical Presentation of Melioidosis in Head and Neck Region N/A
Completed NCT02668406 - Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis
Recruiting NCT00579956 - A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis N/A
Completed NCT02089152 - A Single-blind Stepped Wedge Cluster Randomized Controlled Behaviour Change Trial to Determine Effectiveness of Prevention Programme of Melioidosis in Diabetics in Ubon Ratchathani, Northeast Thailand N/A